Related Experiment Video
Updated: May 7, 2026

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
Published on: February 15, 2019
The regulatory framework for microbiome-based therapies: insights into European regulatory developments
Julie Rodriguez1, Magali Cordaillat-Simmons2, Bruno Pot2,3
1Pharmabiotic Research Institute (PRI), Narbonne, France. julie@pharmabiotic.org.
Abstract:
The emergence of a broad spectrum of microbiome-based therapies has triggered changes in European regulatory frameworks. The first part of the review describes these innovative therapies. The second part provides an overview of the current framework and key changes introduced by the Regulation on substances of human origin (SoHO) for the development of microbiome-based therapies, highlighting the need of microbiome regulatory science to unlock the full potential of microbiome-based therapies.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Microorganisms in Medicine and Therapeutics
Introduction to the Human Microbiota
Development of Human Microbiota
The Oral Microbiota
Human Virome

